@digibete.bsky.socialClinical trials are shaping the future of type 1 treatment!
Learn more, why it matters and how to get involved with #BreakthroughT1D
👉https://www.digibete.org/content/page/clinical-trials-and-research
#Breakthrought1duk #DigiBete #Type1diabetes #Diabetes #T1D #BeTheChange #BeTheProgress
@newsen.bsky.socialFDA Approves Lilly's Onswik: A New Once-Weekly Insulin for Type 2 Diabetes Management #United_States #Indianapolis #Lilly #diabetes #Onswik
@easdnews.bsky.social📢🎤𝐒𝐏𝐄𝐀𝐊𝐄𝐑 𝐇𝐈𝐆𝐇𝐋𝐈𝐆𝐇𝐓: Join Prof. Dame Melanie Davies & Prof. John Buse at #EASD2026 in Milan for the " #ADA / #EASD consensus report on the management of type 2 #diabetes"🇮🇹
📅 Fri, 2 Oct 2026 | 13:00 CEST |📍London Hall
Learn more 👉 pagv3.virtual-meeting.org/EASD/easd202...
@lancetmicrobe.bsky.socialNew personal view article
Metabolism as a missing link between #diabetes, #tuberculosis, and drug resistance?
@pharmaj.bsky.socialIn this feature article #RobBrown highlights how the approval of #teplizumab could be “the biggest breakthrough since the discovery of insulin” in #diabetes treatment and researchers hope it could lead to a “functional cure”
@dengyuemedicine.bsky.social🚨 ~30% of people with Type 1 Diabetes develop chronic kidney disease.
On Sept 17, 2026, the FDA approved Bayer's finerenone (Kerendia®) for CKD in adults with T1D — the first new treatment for this group in 30+ years.
Follow for more diabetes research updates 🧵👇
@byalung.bsky.socialWhat began as worsening leg pain led to a Type 1 diabetes diagnosis for Pax after tests showed extremely high blood sugar and an A1C of 14%. #Type1Diabetes #BloodSugar #Diabetes
@glucoforager.bsky.social🩸 MYTH: One good glucose reading means everything is fine.
Not quite. Your HbA1c, blood pressure, cholesterol and regular health checks help show the bigger picture over time.
One reading is a moment — look at the pattern. 💚
#DiabetesMyths #BloodSugar #GlucoForager #Diabetes #bloodsugar
@kv417.bsky.socialEven a Few Days of Steroid Pills Tied to Pneumonia and Bleeding in #Diabetes
Source: TDKD News
“In adults with type 2, pneumonia risk doubled in days 6 to 30 after short steroid course.
GI bleeding and heart failure were also more likely”
@newsmedical.bsky.socialIs BPA-free actually better? 🧪 New study links BPS - a BPA substitute found in "BPA-free" products - to higher blood sugar in type 2 diabetes. www.news-medical.net/news/2026092... #Diabetes #BPAFree
@omni-letters.bsky.socialUm estudo recente aponta que a variação nos níveis de glicose pode melhorar a qualidade de vida de diabéticos tipo 1 e 2, questionando a eficácia do controle glicêmico rigoroso.
#diabetes #glicemia #qualidadedevida #saude #estudo
@diabetictalks.bsky.socialDiabetes care is about persistence, not perfection. Discover ongoing insights on diabetes and emotions at DiabeticMinds today! www.diabeticminds.com #Diabetes #T1D #T2D #DiabetesAwareness
@thelancetendo.bsky.socialCan we delay the progression of type 1 #diabetes?
Join Chantal Mathieu at The #LancetSummit (30 Nov- 2 Dec, Sitges) to explore the latest advances in #T1D.
Register by Oct 31, 2026 using voucher code TLDC100 to save €100: thelancetsummit.com/diabetes-pre...
@4040rec.bsky.social
@fllics.com
@kill-bait.bsky.social
@progressivepower.bsky.social
@jmirlatestresearch.bsky.social
@cherrywanders.bsky.social
